Compare RGEN & ALK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RGEN | ALK |
|---|---|---|
| Founded | 1981 | 1932 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Air Freight/Delivery Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.6B | 6.4B |
| IPO Year | 1995 | 2003 |
| Metric | RGEN | ALK |
|---|---|---|
| Price | $130.84 | $45.53 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 12 |
| Target Price | ★ $170.18 | $64.58 |
| AVG Volume (30 Days) | 740.6K | ★ 4.5M |
| Earning Date | 04-30-2026 | 04-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 286.96 | N/A |
| EPS | ★ 0.86 | 0.83 |
| Revenue | $141,236,000.00 | ★ $10,426,000,000.00 |
| Revenue This Year | $14.30 | $11.19 |
| Revenue Next Year | $14.52 | $5.11 |
| P/E Ratio | $147.65 | ★ $49.61 |
| Revenue Growth | ★ 35.10 | 8.09 |
| 52 Week Low | $109.66 | $33.03 |
| 52 Week High | $175.77 | $65.35 |
| Indicator | RGEN | ALK |
|---|---|---|
| Relative Strength Index (RSI) | 61.75 | 61.65 |
| Support Level | $130.40 | $38.04 |
| Resistance Level | $135.56 | $54.37 |
| Average True Range (ATR) | 4.47 | 2.26 |
| MACD | 2.40 | 1.17 |
| Stochastic Oscillator | 88.26 | 86.31 |
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia Pacific contribute about 44%, 37%, and 19% of revenue, respectively.
Alaska Air Group Inc operates two airlines, Alaska and Horizon, in three operating segments. The Alaska Airlines segment includes scheduled air transportation on Alaska's Boeing and Airbus jet aircraft for passengers and cargo throughout the U.S., and in parts of Mexico and Costa Rica. The Regional segment includes Horizon's and other third-party carriers' scheduled air transportation for passengers across a shorter distance network within the U.S. and Canada under capacity purchase agreements. The Hawaiian Airlines segment includes scheduled air transportation on Hawaiian's Boeing and Airbus aircraft for passengers and cargo. It earns revenues from Passenger tickets, including ticket breakage and net of taxes and fees, Passenger ancillary, and Mileage Plan passenger revenue.